Security key
74365U107
Protara Therapeutics, Inc. - Common Stock (TARA)
CUSIP: 74365U107
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 10,445,706
- Total 13F value
- $19,115,471
- Share change
- +296,931
- Put/Call ratio
- 20%
- SEC-reported price per share
- $1.83
- Number of holders
- 33
- Value change
- +$384,364
- Number of buys
- 16
- Number of sells
- 14
- Shares outstanding
- 55,913,202
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
33
Top holders
10
TARA full security history
Ownership snapshot
Full 13F holder table
Protara Therapeutics, Inc. SEC filings
Protara Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TARA - Protara Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Comparable ownership
Top 5
Opaleye Management Inc.
4.1%
RA CAPITAL MANAGEMENT, L.P.
3.4%
STEMPOINT CAPITAL LP
1.8%
Boxer Capital, LLC
1.5%
CITADEL ADVISORS LLC
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
3/4/5
Company · 10%+ Owner
|
4.1%
|
$5,299,803
2,304,262 shares
|
— | 30 Jun 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.4%
|
$3,952,000
1,900,000 shares
|
— | 30 Jun 2024 |
| STEMPOINT CAPITAL LP |
13F
Company
|
1.8%
|
$2,046,955
984,113 shares
|
— | 30 Jun 2024 |
| Boxer Capital, LLC |
13F
Company
|
1.5%
|
$1,688,184
811,627 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.2%
|
$1,383,973
665,372 shares
|
— | 30 Jun 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.96%
|
$1,116,611
536,832 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
10,445,706
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
38
Q3 2024 holders
33
Holder diff
-5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|